Hyderabad, January 21st, 2019 : Transcatheter Aortic Valve Replacement (TAVR) is one of the latest advancements in the field of Cardiology and it provides hope for the high risk elderly who need aortic valve replacement. TAVR is an advanced suture less procedure performed to replace damaged aortic valve and is a boon for patients with high surgical risk.
Cardiologists at the Hospital, led by Dr A. Sreenivas Kumar, Sr. Consultant Cardiologist & Director, Cardiology and Clinical Research, Apollo Hospitals, Hyderabad; created history by treating five critically ill patients suffering from valve disease with TAVR on a single day, a feat performed for the first time in the country.
Cardiologists having intensive training in TAVR with dexterity can perform and ensure good outcomes from this complex procedure. An excellent back-up from experienced team and state-of-the-art technology are other prerequisites to its success. Most patients coming for this procedure are in a critical condition and therefore flawless protocol becomes essential, says Dr. K. Hari Prasad, President-Hospitals Division, Apollo Hospitals Group. Apollo Has been in the forefront to bring the best technologies available in the world to fetch the best results for patients here and this procedure is one more in that league. With the improvement in lifestyles and consequent increase in life span, the diseases afflicting elders is also seen more off late and aortic valve disease belongs to that category. 30 to 40% of aortic valve patients, if not treated in time will die within 18 months to 2 years. The gold standard treatment for this is replacing the valve by performing open heart surgery. But 40% of these patients were found to be ineligible for the surgery due to the high risk on account of advanced age and associated health problems. TAVR provides a new lease of life for such patients. The valves used previously were mostly from abroad, but some of these patients got Indian valves. This way a new procedure has come into the access of patients here and also become affordable with Indian valves bringing down the cost, he said.
Five Trans-catheter Aortic valve replacements performed on a single day for the first time in India
The ‘Heart Valve Therapy Program’ is a boon for Indian patients, especially the ones for whom surgery option is closed and are left to endure the problem. The world’s best treatment protocol is now within their reach, says Dr Sreenivas Kumar.
The 14th of January, 2019 was a historic day for Apollo Hospitals as five patients underwent TAVR on a single day, which is an Indian record. All the five were in an advanced age, critical condition and had high risk for open heart surgery for valve replacement. This is the first time such medical feat was performed in India. The five patients treated with TAVR are Mr. Rajesham, a 73 year old male from Siddipet, had severe Aortic Valve Stenosis with moderate L V dysfunction; Mr. Rajendra Prasad, 70 year old male from Hyderabad had Severe Aortic Stenosis with Presncopo with LV dysfunction; Mr. Prasad Rao, a 73 year old male, from Hyderabad, was suffering from severe Aortic Stenosis with Giddinum; Mr. Damodar Das Rathi, a 70 old male from Hyderabad had severe Aortic Stenosis of bioprosthetic valve with LV dysfunction, he had a post surgical Aortic valve replacement in 2009 and Mr. Veeraiah, 66 year old male from Khammam, had Severe Aortic Stenosis, Severe LV dysfunction, Moderate MR and Post PTCA in 2011. All the patients were discharged on the 2nd day of the procedure.
We are extremely delighted at this accomplishment of performing five Transcatheter Aortic Valve Replacements in a day, for the first time in India. It’s an excellent start for a program of this eminence and will give the necessary impetus to make it a grand success benefitting several of our patients, says Dr Sreenivas Kumar. These patients were in a bad shape when they came to us, they were breathless, couldn’t sit, sleep and had to endure terrible discomfort. They were not eligible for a surgery as their heart blood pumping ability was low and their advanced age didn’t help. TAVR came to their rescue. This procedure is safe and effective with 95% success rate and all those with valve disease can avail it, he said.